Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 4%; BSE HEALTHCARE Index Up 0.7%
Wed, 11 Sep 11:55

INDRAPRASTHA MEDICAL Gains 4%; BSE HEALTHCARE Index Up 0.7%Image source: StarLineArts/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 4% and is presently trading at Rs 458.7.

Meanwhile, the BSE HEALTHCARE index is at 44,161.6 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 5.8%) and Natco Pharma (up 3.9%).

ERIS LIFESCIENCES (down 1.3%) and SYNGENE INTERNATIONAL (down 1.2%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 167.0 to Rs 458.7, registering a gain of Rs 291.7 (up 174.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,161.6, registering a gain of 55.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 131.0%), Jubilant Pharmova (up 129.2%) and GRANULES INDIA (up 120.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,996.4 (up 0.1%).

The top gainers among the BSE Sensex today are Asian Paints (up 2.3%) and Bajaj Finance (up 1.9%). The most traded stocks in the BSE Sensex are Tata Motors and MUNDRA PORT & SEZ.

In the meantime, NSE Nifty is at 25,070.0 (up 0.1%). Bajaj Auto and Asian Paints are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,996.4, registering a gain of 14,869.3 points (up 22.2%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 30.4.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 4%; BSE HEALTHCARE Index Up 0.7%". Click here!